Fractional excretion of sodium (FENa) is the amount of salt (sodium) that leaves your body through urine compared to the amount filtered and reabsorbed by the kidney.
FENa is not a test, but rather a calculation based on the concentrations of sodium and creatinine in your blood and urine. Urine and blood chemistry tests are necessary to perform this calculation.
Blood and urine samples are collected at the same time and sent to a lab, where they are examined for their salt (sodium) and creatinine levels.
For information on how a blood sample is taken from a vein, see venipuncture.
For information on giving a urine sample, see clean catch urine sample.
Eat a normal diet with a normal amount of salt, unless otherwise instructed by your doctor.
Your health care provider will instruct you, if necessary, to discontinue drugs that may interfere with test results. Certain diuretic medicines may affect test results.
When the needle is inserted to draw blood, some people feel moderate pain, while others feel only a prick or stinging sensation. Afterward, there may be some throbbing.
The test is usually done for patients who are severely ill with acute kidney insufficiency. The test helps determine if the drop in urine production is due to reduced blood flow to the kidney or to kidney damage itself.
A meaningful interpretation of the test can be made only when your urine volume has dropped to less than 500 mL/day.
A FENa of less than 1% indicates decreased blood flow to the kidney, while a FENa greater than 1% (and usually greater than 3%) suggests kidney damage.
The urine sample has no risk. The risks of drawing blood include:
The test is only of value in specific circumstances such as sudden reduced urine output.
FE sodium; FENa
Landry DW, Basari H. Approach to the patient with renal disease. In: Goldman L, Schafer AI, eds.Cecil Medicine. 24th ed. Philadelphia, PA: Saunders Elsevier; 2011:chap 116.
Updated by: David C. Dugdale, III, MD, Professor of Medicine, Division of General Medicine, Department of Medicine, University of Washington School of Medicine; Herbert Y. Lin, MD, PHD, Nephrologist, Massachusetts General Hospital; Associate Professor of Medicine, Harvard Medical School. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc.
MedlinePlus Topics
Images
Read More
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).
The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed physician should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. Copyright 1997-2012, A.D.A.M., Inc. Duplication for commercial use must be authorized in writing by ADAM Health Solutions.